ライフサイエンスコーパス: operative mortality

1 ospital or within 30 days of operation (1.4% operative mortality).

2 that patient's SES is a strong predictor of operative mortality.

3 There was no operative mortality.

4 al treatment is often denied because of high operative mortality.

5 itate the assessment of strategies to reduce operative mortality.

6 sage in elderly patients, and lower adjusted operative mortality.

7 There was no 30-day operative mortality.

8 ndependently associated with improvements in operative mortality.

9 curred preoperatively may reduce the risk of operative mortality.

10 (MBO) and to identify risk factors affecting operative mortality.

11 ery by developing statistical risk models of operative mortality.

12 etermine whether race affected risk-adjusted operative mortality.

13 Elective aortic-root replacement has a low operative mortality.

14 There was no operative mortality.

15 = 0.001]) were associated independently with operative mortality.

16 (2%) underwent orthopedic procedures with no operative mortality.

17 There were slight improvements in operative mortality.

18 nsplant procedures were performed without an operative mortality.

19 rmine the minimum surgeon volume for optimum operative mortality.

20 e to rescue helps surgeons predict and avoid operative mortality.

21 njury, surgical revision, mediastinitis, and operative mortality.

22 There was no operative mortality.

23 outcome measures after CRC procedures beyond operative mortality.

24 es in the oldest old is focused primarily on operative mortality.

25 tal perioperative blood product exposure and operative mortality.

26 nt has a statistically significant effect on operative mortality.

27 edicts longer hospital stay and greater post-operative mortality.

28 There were no operative mortalities.

29 6+/-5% versus 48+/-4%, P<0.0001), with lower operative mortality (0.5% versus 5.4%, P=0.003) and bett

30 Surgical outcomes and operative mortality (1.4% versus 1.4%; P=1.00) were not

31 ations between matched SIMA and BIMA groups (operative mortality, 10 of 414 [2.4%] versus 13 of 414 [

32 requiring intervention, and there was 1 peri-operative mortality (2.5%).

33 ncreased age was also associated with higher operative mortality (4.83% for >or=75 years vs. 1.09% fo

34 erative complexity must be added to estimate operative mortality accurately.

35 sing logistic regression models, we compared operative mortality across surgeon subspecialties, adjus

36 d and grouped into quintiles according to 1) operative mortality (adjusted for patient characteristic

37 s were significant independent predictors of operative mortality (adjusted odds ratio 5.5, p = 0.036)

38 to evaluate the association between race and operative mortality after AVR or MVR.

39 lack race was not a significant predictor of operative mortality after AVR or MVR; however, black rac

40 Black race is an independent predictor of operative mortality after CABG except for very high-risk

41 whether race is an independent predictor of operative mortality after coronary artery bypass graft (

42 n shown to be an independent risk factor for operative mortality after coronary artery bypass graftin

43 ace is an independent predictor of increased operative mortality after coronary artery bypass surgery

44 fined race as an independent risk factor for operative mortality after coronary artery bypass surgery

45 There was a 70% reduction in operative mortality after EVAR compared with open repair

46 not appear to be a significant predictor of operative mortality after isolated AVR or MVR; however,

47 as infection was responsible for most of the operative mortality after lung transplantation.

48 Operative mortality after TASP implementation fell to 2.

49 ls have been developed to accurately predict operative mortality after valve replacement surgery.

50 Operative mortality also decreased with time.

51 Temporal trends showed that risk of operative mortality, although higher in elderly patients

52 Improvements in length of stay and in operative mortality among elderly patients suggest areas

53 Operative mortality among nursing home residents was sub

54 We had zero operative mortalities and a 10.3% morbidity rate.

55 Moreover, 30-day operative mortality and 12-month mortality were acceptab

56 The primary outcomes were operative mortality and a composite outcome (1 or more o

57 ample were used to measure the likelihood of operative mortality and a prolonged length of stay (LOS)

58 gery offers a chance for cure with excellent operative mortality and acceptable complication rates, e

59 val rate of 43% and 52% respectively with no operative mortality and acceptable perioperative morbidi

60 Operative mortality and actuarial survival were determin

61 Endovascular repair has lower operative mortality and complications and has replaced s

62 like relationship between surgeon volume and operative mortality and determine the minimum surgeon vo

63 tatistically significant association between operative mortality and either treatment group (odds rat

64 air is being explored, with surprisingly low operative mortality and encouraging intermediate results

65 Operative mortality and long-term survival are presented

66 lve repairability and postoperative outcome (operative mortality and long-term survival; all p < 0.00

67 ese patients has been associated with higher operative mortality and lower long-term survival.

68 Outcomes including operative mortality and major morbidity were recorded.

69 sed to determine the association of GFR with operative mortality and morbidities (stroke, reoperation

70 R was one of the most powerful predictors of operative mortality and morbidities.

71 In addition, the operative mortality and morbidity are far in excess of t

72 s have resulted in a significant decrease in operative mortality and morbidity for older patients.

73 15 level is an independent predictor of post-operative mortality and morbidity in cardiac surgery pat

74 eling was performed to provide risk-adjusted operative mortality and morbidity odds ratios.

75 Operative mortality and morbidity rates were 9% and 31%,

76 version to on-pump have significantly higher operative mortality and morbidity than either completed

77 Operative mortality and morbidity, and disease-free surv

78 Surgical indications, operative mortality and morbidity, and hematological out

79 ults to first hepatic operations in terms of operative mortality and morbidity, survival, disease-fre

80 uation of outcomes cannot be limited to only operative mortality and morbidity.

81 nt long-term relief of symptoms with minimal operative mortality and morbidity.

82 ed over time, with significant reductions in operative mortality and perioperative complications.

83 Variables associated with the end points of operative mortality and postoperative SCI were assessed

84 on models, we examined the relations between operative mortality and surgeon volume and hospital volu

85 n between older donor age and increased post-operative mortality and TCAD, it is more beneficial in t

86 egression was used to identify predictors of operative mortality and to estimate weights for an addit

87 We compared operative mortality and use of invasive interventions (m

88 Age at operation had no effect on operative mortality, and late mortality was significantl

89 e, we examined isolated CABG surgery volume, operative mortality, and the composite end point of oper

90 Primary outcomes examined included operative mortality, aneurysm rupture, aneurysm-related

91 w transvalvular mean gradient, and increased operative mortality, aortic valve replacement was associ

92 ved associations between hospital volume and operative mortality are largely mediated by surgeon volu

93 Operative mortality associated with valve replacement su

94 Operative mortality before TASP implementation was 33.9%

95 The main outcome measure was operative mortality (before discharge or within 30 days

96 surgery, MV repair was associated with lower operative mortality, better long-term survival, and fewe

97 resection rate, number of nodes examined or operative mortality between gastrectomy and esophagectom

98 Absolute differences in operative mortality between VLVH and VHVH were somewhat

99 Of the 84 patients, there were 2 operative mortalities both in class IV aortic patients f

100 There was no operative mortality, but permanent pacing was needed in

101 Surgery for post-MI PMR involves a notable operative mortality, but there are recent trends for low

102 A risk model for operative mortality (c-index 0.81) revealed a risk-adjus

103 each of the 4 procedures, adjusted rates for operative mortality, complications, and readmissions wer

104 transfusion was an independent predictor of operative mortality, complications, major complications,

105 Although operative mortality continues to decrease over time, spe

106 ed the extent to which racial differences in operative mortality could be accounted for by the hospit

107 , and comorbid conditions, the risk-adjusted operative mortality (death before discharge or within 30

108 logistic regression to assess differences in operative mortality (death within 30 days or before disc

109 gh 1985; 55% in 1991 through 1995, P < .05), operative mortality declined (13% in 1966 through 1985;

110 Operative mortality declined during the study period for

111 Operative mortality declined for all eight procedures, r

112 Although operative mortality decreased from 4.1% to 2.9% (adjuste

113 an increase in concomitant major procedures, operative mortality decreased from approximately 4% in t

114 However, total pancreatectomy operative mortality decreased over time (1970-1989, 40%;

115 atient risk and clustering effects, rates of operative mortality decreased with increasing hospital C

116 Operative mortality (defined as a death occurring within

117 ailure, reoperation for bleeding, stroke, or operative mortality did not differ in the two groups.

118 Disparities in operative mortality due to socioeconomic status (SES) ha

119 The magnitude of the volume-operative mortality effect varied from an adjusted odds

120 tries with the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) randomized tria

121 ncluded in the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) randomized tria

122 fairs AWESOME (Angina With Extremely Serious Operative Mortality Evaluation) study randomized trial a

123 Influence of beta-blockers on operative mortality, examined using both direct risk adj

124 amine the effect of subspecialty training on operative mortality following lung resection.

125 Surgeon volume was inversely related to operative mortality for all eight procedures (P=0.003 fo

126 Finally, operative mortality for isolated tricuspid valve surgery

127 risk factors were the major determinants of operative mortality for most civilian surgical cases.

128 Unadjusted operative mortality for MVR only was 5.60% for blacks ve

129 Patient risk factors alone accounted for operative mortality for operations less than level 4 (95

130 ational study demonstrates an improvement in operative mortality for patients undergoing pancreatecto

131 ents also experienced higher rates of 30-day operative mortality (>80 years vs. 45-55 years; 6% vs. <

132 isk surgery have changed as a result and how operative mortality has been affected.

133 ver, despite an increase in surgical volume, operative mortality has not changed.

134 Operative mortality has traditionally been assessed at 3

135 established, relationships between race and operative mortality have not been assessed systematicall

136 Along with lower operative mortality, HVHs have better late survival rate

137 gitation can be performed with an acceptable operative mortality if patients undergo surgery before t

138 The rate of operative mortality in appropriately selected patients i

139 Using national Medicare files, we examined operative mortality in approximately 461,000 patients un

140 Operative mortality in both the cardiac and pulmonary tr

141 al features and outcomes or risk factors for operative mortality in cardiogenic shock (CS) patients u

142 on, was associated with significantly higher operative mortality in comparison with patients with non

143 Operative mortality in CS patients was high and surgery

144 care database (1994 to 1999), we studied the operative mortality in patients undergoing 4 cardiovascu

145 We then compared operative mortality in patients undergoing surgery at ve

146 and reoperation are predictors of increased operative mortality in patients with ventricular dysfunc

147 aft dysfunction was the most common cause of operative mortality in the heart transplant group wherea

148 There was no operative mortality in the patients undergoing mitral va

149 om liver failure in the non-PVE group and no operative mortality in the PVE group.

150 Operative mortality in the series of 500 patients was 1.

151 significant association between CON law and operative mortality in the South.

152 ospital CABG procedural volume and all-cause operative mortality (in-hospital or 30-day, whichever wa

153 41-50 years, 51-60 years, and >60 years) and operative mortality (in-hospital or within 30 days), adj

154 bility of curative resection with negligible operative mortality, incidental MD is best treated with

155 An acceptable operative mortality, increased and improved quality of l

156 Some, but not all, of this variation in operative mortality is attributable to hospital and surg

157 tic aneurysms smaller than 5.5 cm, even when operative mortality is low.

158 n of women are not offered intervention, and operative mortality is much higher in women for both EVA

159 The relationship between age and operative mortality is not linear, manifesting a steeper

160 rse relationship between hospital volume and operative mortality is well-established for esophageal,

161 ital volume may be an important predictor of operative mortality, it is not associated with resource

162 Operative mortality (< or =30 days) in the extracted stu

163 rated on in advanced repair centres with low operative mortality (<1%) and high repair rates (>/=80-9

164 midsternotomy, no renal failure, strokes, or operative mortality (<30 days), transient ischemic attac

165 tality and a composite outcome (1 or more of operative mortality, major adverse event, prolonged hosp

166 val, (3) reintervention rate, and (4) 30-day operative mortality, morbidity, and wound and access com

167 one patients (17.0%) had a complication, and operative mortality occurred in 27 patients (mortality r

168 dentified CAD as an independent predictor of operative mortality (odds ratio [OR] = 2.35, P = 0.012),

169 and PLF group were independent predictors of operative mortality (odds ratio [OR]: 1.18, p < 0.05; an

170 rtery bypass graft was associated with lower operative mortality (odds ratio, 0.18; 95% CI, 0.04 to 0

171 70 years of age demonstrated a reduction in operative mortality (odds ratio, 0.80 per year after reg

172 R, the presence of LGE predicted higher post-operative mortality (odds ratio: 10.9; 95% confidence in

173 e or two units or more than two units had an operative mortality of 2.5% and 11.1%, respectively, com

174 e findings were obtained despite a low total operative mortality of 2.7 percent in the immediate-repa

175 Operative mortality of the 3 age groups (1.2%, 4.1%, and

176 Women have a higher operative mortality (OM) after coronary artery bypass gr

177 ot associated with significant reductions in operative mortality or complications.

178 Patients with operative mortality or incomplete resection (R2) were ex

179 ve mortality, and the composite end point of operative mortality or major morbidity for the years 200

180 Variables associated with the endpoints of operative mortality or major morbidity, particularly spi

181 Historical measures of operative mortality or procedure volume identify hospita

182 e anatomic site without substantial risk for operative mortality or recurrent infection.

183 Peri-operative mortality (OR 0.81, 95% CI 0.34-1.93; p=0.63)

184 t speed remained independently predictive of operative mortality (OR, 1.11 per 0.1-m/s decrease in ga

185 Thus, operative mortality (overall, 18.5%) decreased from 67%

186 Operative mortality (p < .01) and hospital stays (p < .0

187 Observed risks of operative mortality (P=0.04) and composite outcome (P<0.

188 Number of episodes (P=0.18), operative mortality (P=0.048), stroke (P=0.126), and dis

189 However, despite higher operative mortality, patients with LFLG-AS undergoing ao

190 Operative mortality, postoperative complications, and FT

191 storic control subjects in the parameters of operative mortality, postoperative renal failure, and lo

192 ase, the liver transplant group had a higher operative mortality rate (19%) than did either of the sh

193 epatectomy can be performed with a near-zero operative mortality rate and is associated with long-ter

194 There was a 5.3% operative mortality rate during the 22 years of the revi

195 The operative mortality rate for all patients studied was 3.

196 There is a low 5.8% operative mortality rate for patients requiring uncompli

197 during the 22 years of the review, with a 2% operative mortality rate in the last 100 patients.

198 stically improved compared with the expected operative mortality rate of 18.2% (observed-to-expected

199 Major treatment harms include an operative mortality rate of 2% to 6% and significant ris

200 was statistically equivalent to the expected operative mortality rate of 26.0% (observed-to-expected

201 omplication rate was 30.7% (n = 39), and the operative mortality rate was 0.8% (n = 1).

202 The operative mortality rate was 1.02% (16/1575) in the solo

203 Operative mortality rate was 10%, and was associated wit

204 The operative mortality rate was 10+/-3% (+/-70% confidence

205 Operative mortality rate was 10.5% (2/19), postoperative

206 The operative mortality rate was 2.2% without APBF and 5.4%

207 The 30-day operative mortality rate was 3%, with an overall actuari

208 Operative mortality rate was 5.0%, with a major morbidit

209 In all Eras, the operative mortality rate was directly related to Child's

210 The operative mortality rate was higher in group 2 (7.8%) th

211 The operative mortality rate was higher with LoEF (14%) than

212 ormed for malignancy with an acceptable peri-operative mortality rate.

213 sing administrative health data, we compared operative mortality, rate of surgical complications, len

214 fewer emergency operations and lower 30-day operative mortality rates at up to 10- to 15-year follow

215 Operative mortality rates decreased for esophageal, panc

216 Operative mortality rates do not decline as surgical tra

217 Operative mortality rates for AVR, MVR, combined CABG/AV

218 d that in California during the early 1990s, operative mortality rates for esophageal, pancreatic, an

219 The operative mortality rates for groups 1 and 2M were 0% an

220 Operative mortality rates for pancreaticoduodenectomy ar

221 the initial studies to determine if: (a) the operative mortality rates had decreased; and (b) a great

222 Variation in post-operative mortality rates has been associated with diffe

223 bypass grafting (CABG) volume and lower CABG operative mortality rates in elderly patients.

224 We compared operative mortality rates in July relative to all other

225 hose with low procedure volumes, have higher operative mortality rates than their younger counterpart

226 Expected operative mortality rates were calculated using the Inte

227 Baseline risk profiles and expected operative mortality rates were comparable between patien

228 Adjusted operative mortality rates were lowest for cardiothoracic

229 Adjusted operative mortality rates were no higher in July than in

230 h severe AR and markedly low EF incur excess operative mortality rates, postoperative mortality rates

231 icant improvements in diagnostic imaging and operative mortality rates.

232 significant monthly or seasonal variation in operative mortality rates.

233 nformation has affected referral patterns or operative mortality rates.

234 -intervention review), and 30-day mortality (operative mortality review) after intact aneurysm repair

235 -intervention review), and 50 women (for the operative mortality review).

236 These factors can be used in determining operative mortality risk and whether elective surgical p

237 in patient SES results in a mean decrease in operative mortality risk of 7.1%.

238 Operative mortality risk was estimated statistically by

239 r, both methods modestly overestimate actual operative mortality risk.

240 Both methods modestly overestimated operative mortality risk.

241 ulmonary bypass time were linked with higher operative mortality risk; older age, emergency operation

242 Black patients have higher operative mortality risks across a wide range of surgica

243 Operative mortality rose inversely with declining renal

244 esults were for esophagectomy, for which the operative mortality rose to 17.3% in low-volume hospital

245 ciety of Thoracic Surgeons Predicted Risk of Operative Mortality score (10.9% vs. 8.1%; p < 0.001) an

246 bid patients, etc.) can be performed with an operative mortality similar to standard sternotomy appro

247 Operative mortality steadily declined and was 2% (one of

248 There was no difference in operative mortality, sternal wound infection, or total c

249 strated decreases in expected risk of 30-day operative mortality (STS Predicted Risk of Mortality [PR

250 e women, with a median STS Predicted Risk of Operative Mortality (STS PROM) score of 7.1%.

251 After adjustment for early (operative) mortality, surgery was not associated with a

252 Endovascular repair is associated with lower operative mortality than open repair, similar mid-term m

253 embolization (PVE) had a significantly lower operative mortality than those patients without hypertro

254 Despite its strong association with 30-day operative mortality, the impact of older age was compara

255 its most severe form, increases the odds of operative mortality three to eight-fold.

256 e of surgical complications (four patients), operative mortality (two patients), or ineligibility for

257 ma (PHC) is high-risk surgery, with reported operative mortality up to 17%.

258 Operative mortality was 0%.

259 Operative mortality was 0.6%, and postoperative and late

260 Operative mortality was 0.8% (n=10) in the MultArt and 2

261 Operative mortality was 1 of 26 patients (3.8%), dramati

262 Operative mortality was 1.4% (n = 3).

263 The operative mortality was 1.68%.

264 Overall operative mortality was 11.4% (19/167), but higher in pa

265 Operative mortality was 12% (10 of 85).

266 Operative mortality was 12/526 (2%) in the AV and 1/474

267 Operative mortality was 2.52% for CON versus 2.62% for n

268 The overall operative mortality was 2.66%.

269 The 30-day operative mortality was 2.9% ().

270 Operative mortality was 3.1% overall and was progressive

271 ital stay was 8 days, morbidity was 45%, and operative mortality was 3.1%.

272 Operative mortality was 3.4% for elective cases and 15.4

273 Operative mortality was 3.4%.

274 Ninety-day operative mortality was 3.5%.

275 Operative mortality was 3.83% for blacks versus 3.14% fo

276 Operative mortality was 3.9% for patients undergoing rep

277 Operative mortality was 3.9%.

278 The 30- day operative mortality was 5.3%.

279 Operative mortality was 6.6%; survival at 3 and 5 years

280 Operative mortality was 7.5% but was 2.8% over the last

281 Operative mortality was 8.3% and was associated with non

282 ility of preoperative MELD scores to predict operative mortality was evaluated in subjects enrolled i

283 A significant interhospital variability in operative mortality was evident with increasing age (var

284 ion, the relationship between age and 30-day operative mortality was found to be nonlinear.

285 Operative mortality was highest in patients with acute m

286 eloped AAD late after the initial operation, operative mortality was highest in patients without preo

287 the fastest gait speed tertile (>1.00 m/s), operative mortality was increased for those in the middl

288 le analysis, the association between BMI and operative mortality was no longer significant.

289 Although peri-operative mortality was similar (2.6% vs. 2.2%, p = NS),

290 Operative mortality was similar (African American versus

291 The operative mortality was the highest in patients with pre

292 Operative mortality was zero.

293 Operative mortalities were similar in women and men (3.9

294 Complications and operative mortality were evaluated for the entire cohort

295 to identify older patients at higher risk of operative mortality were greater than 74, 78, and 75 yea

296 ne the relationship between surgeon type and operative mortality while accounting for patient and hos

297 Operative mortality with high-risk surgery fell substant

298 Operative mortality with lung resection varies by surgeo

299 pital procedure volume is clearly related to operative mortality with many cancer procedures, its eff

300 Patients undergoing resection had a 9% operative mortality, with morbidity of 40%.